Managing VTE: A concise review of NOACs

Managing VTE: A concise review of NOACs

Cardiology
A badge with ribbon in color black Point(s): 1 | An analog clock in color black 20 minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 23 Apr 2022 

Overview

NEW!

MPS Code: 0195/2021

Venous thromboembolism (VTE) is the third most common cardiovascular disease after myocardial infarction and stroke. The goal of this learning activity is to provide pharmacists with a comprehensive review on the role of non-vitamin K antagonist oral anticoagulants (NOACs) in the management of VTE. 

Upon completing this module, participants will have a better understanding of the following:

● Epidemiology and burden of disease

● Anticoagulant therapy

● The efficacy and safety profile of NOACs in the acute and extended treatment of VTE


Who should participate:
Pharmacists

NOTE :
Please read thoroughly & understand the module before attempting the assessment questions.

Terms & Conditions: 
 Participants must obtain a minimum score of 7/10 (70%) to be awarded 1 point.
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points.

The modules/articles are best viewed with:
Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards-compliant browser may be required to view the modules.  

Sponsored by:

Pfizer_logo.jpg